Aortic telomere length as a potential predictive factor for post transplant allograft function

26 May 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Jevgenija Vymetalova

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

13 More presentations in this session

Presentation thumbnail

Elamipretide restores protein and mRNA expression levels of S100A1 in left ventricular myocardium of dogs with chronic heart failure

Professor H. Sabbah (Detroit, US)

Presentation thumbnail

Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats

Miss M. Krasnova (Saint Petersburg, RU)

Abstract Slides

Presentation thumbnail

Introducing SGLT2 inhibitors during hospitalization. Safety and outocmes.

Doctor F. Camacho Jurado (Puerto Real, ES)

Presentation thumbnail

Outcome evaluation of the association of sacubitril/valsartan and iSGLT2 in diabetic patients with heart failure with reduced ejection fraction.

Doctor F. Camacho Jurado (Puerto Real, ES)

Presentation thumbnail

Outcome evaluation of Sacubitril/Valsartan in patients with Heart Failure and reduced ejection fraction with regular follow-up meetings in a Spanish heart failure day-hospital.

Doctor F. Camacho Jurado (Puerto Real, ES)

Access the full session

Session thumbnail

Poster session 1 - Basic Science - Chronic Heart Failure – Treatment

The Event

Heart Failure 2018

26 May - 29 May 2018

You may be interested in

Congress Presentation

Dealing with Heart Failure (again) after Cardiac Transplant

Congress Presentation

Hemochromatosis-induced cardiomyopathy

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources